Mrv0541 05041404482D 17 17 0 0 1 0 999 V2000 2.1434 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 0.8250 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 0.0000 0.8250 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 0.0000 0.0000 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 0.7145 1.2375 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 0.7145 -0.4125 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 2.8579 0.8250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.7145 1.2375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.7145 -0.4125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -1.2375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 -0.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 2.0625 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 1.1468 1.6002 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.5303 0.1930 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.8125 0.1433 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1.2448 1.8695 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.0000 -0.8250 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 1 0 0 0 4 3 1 0 0 0 0 5 2 1 0 0 0 0 5 3 1 0 0 0 0 6 4 1 0 0 0 0 7 1 1 0 0 0 0 3 8 1 1 0 0 0 4 9 1 6 0 0 0 6 10 1 1 0 0 0 11 2 1 0 0 0 0 11 6 1 0 0 0 0 5 12 1 6 0 0 0 2 13 1 6 0 0 0 3 14 1 6 0 0 0 4 15 1 1 0 0 0 5 16 1 1 0 0 0 6 17 1 6 0 0 0 M END > DB03584 > drugbank > [H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(S)[C@]([H])(O)[C@@]1([H])O > InChI=1S/C6H12O5S/c7-1-2-5(12)3(8)4(9)6(10)11-2/h2-10,12H,1H2/t2-,3-,4-,5-,6-/m1/s1 > KGSURTOFVLAWDC-QZABAPFNSA-N > C6H12O5S > 196.221 > 196.040544184 > 5 > 24 > -0.003246544956827727 > 18.361720240987516 > 1 > 5 > 0 > 0 > (2R,3R,4R,5S,6R)-6-(hydroxymethyl)-5-sulfanyloxane-2,3,4-triol > -1.36 > -1.977252249333333 > -0.57 > 0 > 0 > 1 > 0 > 11.33903653750651 > 9.493529658123693 > -2.9603616911099078 > 90.15 > 42.133399999999995 > 1 > 1 > 5.30e+01 g/l > tetrahydrofolic acid > 0 > DB03584 > EXPT01645; EXPT02895; EXPT01648; DB03188; DB03599 > experimental > 4-Thio-beta-D-glucopyranose > 4-deoxy-4-Thio-beta-D-glucopyranose; 4-Thio-β-D-glucopyranose $$$$